News & Events

All the latest news and events from PhoreMost

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development
4th November 2019

PhoreMost and Sentinel Oncology expand collaboration to jointly accelerate novel glioma therapeutic through preclinical development

Lead allosteric PLK1 inhibitor to progress through preclinical and IND enabling studies PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, and Sentinel Oncology, today announced an expansion of their collaboration to accelerate the progression of SOL686, a novel allosteric Polo-like kinase 1 (PLK1) inhibitor, through preclinical dev …

Event

JP Morgan Annual Healthcare Conference

13th to 16th January 2020
Event

SLAS

25th to 26th January 2020